Congenital Disorders of Glycosylations (CDGs) are a group of metabolic disorders characterized by defective N-terminal glycosylation of proteins. This, in turn leads to the build-up of intermediate chemical compounds in the body, causing a variety of complications.
CDG1B is caused by mutations in the gene encoding mannosephosphate isomerase.